Huepenbecker, Sarah P.
Fu, Shuangshuang
Sun, Charlotte C.
Zhao, Hui
Primm, Kristin M.
Giordano, Sharon H.
Meyer, Larissa A.
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA101642, CA217685, NIH/NCI P30 CA016672)
Article History
Received: 16 June 2022
Accepted: 28 August 2022
First Online: 30 October 2022
Disclosure
: Larissa A. Meyer reports consulting fees from Bristol Meyers Squibb, advisory board participation for GlaxoSmithKline, and stocks in Crisper, Invitae, and Bristol-Myers Squibb. Charlotte C. Sun reports partial research funding from AstraZeneca and stock in Inform Genomics. Sarah P. Huepenbecker, Shuangshuang Fu, Hui Zhao, Kristin M. Primm, and Sharon H. Giordano report no conflicts of interest.